Cargando…
Photodynamic Priming Improves the Anti-Migratory Activity of Prostaglandin E Receptor 4 Antagonist in Cancer Cells In Vitro
SIMPLE SUMMARY: Photodynamic priming is an emerging strategy that leverages subtherapeutic photochemistry for therapeutic benefits, often used as part of combination regimens. Our study aimed to couple photodynamically priming with antagonism of the prostaglandin E receptor 4, a therapeutic target l...
Autores principales: | Sorrin, Aaron J., Liu, Cindy, Cicalo, Julia, Reader, Jocelyn, Najafali, Daniel, Zhang, Yuji, Roque, Dana M., Huang, Huang-Chiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582354/ https://www.ncbi.nlm.nih.gov/pubmed/34771424 http://dx.doi.org/10.3390/cancers13215259 |
Ejemplares similares
-
Evolutionary dynamics of cancer multidrug resistance in response to olaparib and photodynamic therapy
por: Baglo, Yan, et al.
Publicado: (2021) -
Immunological and Toxicological Considerations for the Design of Liposomes
por: Inglut, Collin T., et al.
Publicado: (2020) -
Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response
por: Rickard, Brittany P., et al.
Publicado: (2021) -
Transient fluid flow improves photoimmunoconjugate delivery and photoimmunotherapy efficacy
por: Sorrin, Aaron J., et al.
Publicado: (2023) -
Eicosanoids in Cancer: Prostaglandin E(2) Receptor 4 in Cancer Therapeutics and Immunotherapy
por: Ching, Mc Millan, et al.
Publicado: (2020)